Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.
Charles Taylor, Founder and Chief Technology Officer at HeartFlow, explores how artificial intelligence (AI) is helping to fix the gender disparities in healthcare.
Dr Faz Chowdhury, CEO at Nemaura Medical (Nasdaq: NMRD), aims to stem the tide of the onset of diabetes and help to manage and reverse Type 2 diabetes using the world’s first daily-wear non-invasive CGM technology.
The World Health Organisation on Friday (18 June) said that the Delta variant, originating in India, would be globally dominant due to "significantly increased transmissibility".
Here, Fraunhofer Germany discuss how COVID-19 has driven the adoption of digital health technologies, and offers solutions aiding healthcare professionals to keep up.
The German-made CureVac vaccine has given a result of 47% efficacy, much lower than expected - now, the proposed delivery of 225 million doses to the EU is at risk.
Over half of global cardiovascular disease (CVD) deaths in 2019 happened in Asia - now, scientists are drawing attention to rapidly climbing figures, as heart issues continue to be a risk factor for severe COVID.
Scientists tested makeup across the US and Canada for harmful chemicals - they found that over 75% of products tested contained PFAS, which are "forever chemicals".
The UK Government will make COVID vaccination mandatory for care home workers, with the possibility that NHS workers will also be required to get the jab.
Here, Ingrid R. Niesman, M.S., Ph.D. explains her research into a potential untapped model system, highlighting unmistakable similarities between human neurogenerative diseases and feline cognitive dysfunction syndrome.
The UK's Alpha variant became one of the most highly transmitted forms of the virus, which led to other variants mutating into existence - now, scientists are picking up on the beginnings of a "Mexican variant", yet to be named under the WHO system.
A team at Newcastle University have identified a gene, HLA-DRB1*04:01, which could be responsible for individuals who are asymptomatic - suggesting that the gene offers some protection against severe COVID.
